SEARCH

SEARCH BY CITATION

Disclaimer: Supplementary materials have been peer-reviewed but not copyedited.

FilenameFormatSizeDescription
humu22399-sup-0001-suppmat.pdf358K

Figure S1. Multiple Sequence Alignment of TTI2/C8orf41 representative orthologs shows amino acid conservation of the mutated residue across species.

Figure S2. TTI2 silencing in HEK293 cells. HEK293 cells were co-transfected with RNAi oligonucleotides directed against TTI2 or an negative control RNAi oligonucleotides using Lipofectamine RNAi MAX (Invitrogen) according to the manufacturer's protocols.

Table S1. Summary of the clinical characteristics of children with TTI2 mutation

Table S2. IBD regions

Table S3. Number of variants identified by whole-exome sequencing

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.